ClinicalTrials.Veeva

Menu

Bile Acid-induced GLP-secretion. A Study in Cholecystectomized Subjects

U

University Hospital, Gentofte, Copenhagen

Status

Completed

Conditions

Diabetes

Study type

Observational

Funder types

Other

Identifiers

NCT01251510
GAL-INK I

Details and patient eligibility

About

PURPOSE

The goal of the present project is to unravel the importance of bile acid-induced GLP-1 secretion (via the G protein-coupled receptor TGR5) in human physiology.

In the present study the investigators examine the GLP-1 secretion in healthy subjects and cholecystectomised patients. Thereby the investigators aim to show, that cholecystectomised patients have reduced bileflow after a meal, and as a consequence exhibit a diminished GLP-1 response as compared to healthy subjects.

Enrollment

20 patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: (Healthy)

  • Normal fasting plasma glucose
  • Normal glucose tolerance
  • Normal haemoglobin levels
  • Informed content

Inclusion Criteria: (cholecystectomy group)

  • Laparoscopic cholecystectomy <6 months. Indication: Gallstones.
  • Normal fasting plasma glucose
  • Normal glucose tolerance
  • Normal haemoglobin levels
  • Informed content

Exclusion Criteria: (both groups)

  • Diabetes
  • Pre diabetes (impaired glucose tolerance or impaired fasting glucose)
  • 1st degree relatives with diabetes
  • Obesity (BMI > 30)
  • Inflammatory bowels disease
  • Nephropathy
  • Liver disease
  • Medication which cannot be on hold for 24h

Trial design

20 participants in 2 patient groups

Healthy adults
Type 2 diabetes

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems